Modernizing Opioid Treatment Access Act 2.0 of 2026 expands access to methadone for opioid use disorder through pharmacies.

Modernizing Opioid Treatment Access Act 2.0 of 2026 amends the Controlled Substances Act to expand access to methadone for opioid use disorder through pharmacies. It allows qualified practitioners to prescribe methadone for dispensing through pharmacies, with specific informed consent requirements. The Attorney General can cease, revoke, or deny registrations at a state's request. The Act also mandates annual reporting by the Drug Enforcement Administration on registered practitioners and revocations. The changes take effect 180 days after enactment.

Modernizing Opioid Treatment Access Act 2.0 of 2026 expands access to methadone for opioid use disorder through pharmacies.

Modernizing Opioid Treatment Access Act 2.0 of 2026 amends the Controlled Substances Act to expand access to methadone for opioid use disorder through pharmacies. It allows qualified practitioners to prescribe methadone for dispensing through pharmacies, with specific informed consent requirements. The Attorney General can cease, revoke, or deny registrations at a state's request. The Act also mandates annual reporting by the Drug Enforcement Administration on registered practitioners and revocations. The changes take effect 180 days after enactment.